Figures computed from official regulatory filings — .
Analysttarget 120 USD (+15485%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 0.61% · institutions 1% · short 6.4% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Calidi Biotherapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
4 buys3 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Peoples George | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sanders Corazon (Corsee) D. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Leftwich Scott | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Poma Eric E | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Schoeneck James Atrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stewart Alan R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jackson Andrew C.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Fernandez Santidrian Antonio | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Camaisa Allan | Sell | $1.2K | SEC |
| Fernandez Santidrian Antonio | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Jackson Andrew C.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Poma Eric E | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Poma Eric E | Buy | $50K | conv 95ClusterFirst in 12mo | SEC |
| Jackson Andrew C.track record | Buy | $5K | conv 83ClusterFirst in 12mo | SEC |
| Schoeneck James Atrack record | Buy | $150K | conv 81ClusterUnusual size | SEC |
| Leftwich Scott | Buy | $250K | conv 86ClusterFirst in 12mo | SEC |
| Schoeneck James Atrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster | SEC |
| Jackson Andrew C.track record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Poma Eric E | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Leftwich Scott | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Schoeneck James Atrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stewart Alan R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Peoples George | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Leftwich Scott | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Poma Eric E | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |